Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)

WTC Health Program R21: Exploratory Research on 9/11-Related Health Conditions

This program funds early-stage research addressing diagnostic and treatment uncertainties in individuals monitored or treated under the James Zadroga 9/11 Health and Compensation Act. The WTC Health Program seeks exploratory and developmental projects that test feasibility of novel investigative approaches with potential to improve clinical outcomes for this population. Research may target new interventions, diagnostic techniques, methodologies, or models that could yield breakthroughs in managing 9/11-related health conditions—including respiratory, cancer, and mental health sequelae. Studies should break new ground or extend existing discoveries in new directions; applicants typically propose work with minimal or no preliminary data, making this suitable for high-risk, high-reward conceptual investigations.

• Who can apply: U.S. institutions and researchers eligible for NIH funding; critical restriction: research must address diagnostic or treatment uncertainty in WTC-exposed individuals under the Zadroga Act framework.
• Funding & project length: Not stated.
• Award mechanism: R21 (exploratory/developmental research grant).
• Key dates: Not stated.
• Best fit for: Clinical researchers, occupational/environmental health scientists, and epidemiologists studying 9/11-exposed populations; approaches may include biomarker discovery, intervention development, or diagnostic validation.